This document discusses treatment options for nasopharyngeal carcinoma. It notes that rates of the cancer vary significantly around the world. Surgical intervention is challenging due to the anatomic location. As a result, radiotherapy alone or combined with chemotherapy are the primary treatments. A previous meta-analysis found that adding chemotherapy to radiotherapy improves overall survival, particularly with concomitant (simultaneous) chemotherapy and radiotherapy. This study aims to update that meta-analysis and separately analyze the benefit of concomitant plus adjuvant chemotherapy. Survival curves are presented comparing radiotherapy alone versus combined with chemotherapy. The analysis confirms benefits of adding chemotherapy to radiotherapy, especially with concomitant administration, but the benefits of adjuvant chemotherapy require further assessment.